5-Bromosalicylic acid → 5-Bromo-N-[3,5-bis[(1,1-dimethyl)ethyl]phenyl)-2-hydroxybenzamide

HRID 1865379노트

반응식

HRID 1865379 반응식
[Br:1][C:2]1[CH:10]=[C:6]([C:7]([OH:9])=O)[C:5]([OH:11])=[CH:4][CH:3]=1.[CH3:12][C:13]([C:16]1[CH:17]=[C:18]([CH:20]=[C:21]([C:23]([CH3:26])([CH3:25])[CH3:24])[CH:22]=1)[NH2:19])([CH3:15])[CH3:14]>>[Br:1][C:2]1[CH:3]=[CH:4][C:5]([OH:11])=[C:6]([CH:10]=1)[C:7]([NH:19][C:18]1[CH:20]=[C:21]([C:23]([CH3:25])([CH3:24])[CH3:26])[CH:22]=[C:16]([C:13]([CH3:15])([CH3:14])[CH3:12])[CH:17]=1)=[O:9]

참가 물질

3

반응물 2

HCID 69725-Bromosalicylic acidHCID 754193,5-Di-tert-butylaniline

생성물 1

HCID 237297945-Bromo-N-[3,5-bis[(1,1-dimethyl)ethyl]phenyl)-2-hydroxybenzamide수율 45.2%

실험 절차

Using 5-bromosalicylic acid and 3,5-bis[(1,1-dimethyl)ethyl]aniline as the raw material, the same operation as the Example 1(1) gave the title compound.

출처 및 근거

ORD 기록
ord-4ddc43496b3a46dd9c325497d0ff9d9b
출처 데이터셋
uspto-grants-2009_12
특허 번호
US07626042B2

반응 노트

불러오는 중…